DUBLIN–(BUSINESS WIRE)–The “MBA Strategic Thinking for Pharma and Biopharma Professionals Training Course (Feb 23rd – Feb 24th, 2026)” training has been added to ResearchAndMarkets.com’s offering. Working in the highly competitive pharmaceutical industry, with ever-increasing change and pressure, is probably one of the most challenging managerial roles of any industry today. This MBA strategic thinking workshop … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announced today that it will participate in the 44th Annual J.P. Morgan Healthcare Conference, San Francisco, USA, to be held on January … [Read more…]

TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive … [Read more…]

BRISBANE, Calif.–(BUSINESS WIRE)–CareDx, Inc. (Nasdaq: CDNA) today provided notice of proposed settlement of derivative actions and settlement hearing. UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA JEFFREY EDELMAN, JAYSEN Case No. 3:25-cv-02036-TLT STEVENSON, and CHRISTIAN JACOBSEN, (Shareholder Derivative Action) Derivatively on Behalf of CareDx, Inc.,     SUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF … [Read more…]

SUNNYVALE, Calif.–(BUSINESS WIRE)–EBR Systems, Inc., developer of the world’s only left ventricular wireless cardiac pacing device for heart failure, today announced that management will be presenting at the J.P. Morgan 2026 Healthcare Conference on Thursday, January 15, 2026, at the Westin St. Francis in San Francisco, CA. About EBR Systems EBR Systems is a cardiac … [Read more…]

NEW YORK–(BUSINESS WIRE)–OPUM Technologies (“OPUM”), a medical technology company redefining how knee health, performance, and recovery are measured, today announced continued expansion of its Digital Knee® platform, an AI-powered wearable and analytics system designed to deliver continuous, clinical-grade biomechanical intelligence. As OPUM accelerates adoption across orthopedic care, rehabilitation, and elite sports environments, the company has … [Read more…]

New AI-powered platform provides real-time insights into antioxidant health, transforming how people understand and manage their nutritional wellness PROVO, Utah–(BUSINESS WIRE)–Nu Skin Enterprises Inc. (NYSE: NUS), the world’s #1 company for beauty and wellness device systems*, introduced Prysm iO™, a breakthrough intelligent nutritional wellness platform designed to provide powerful insights into one’s personal health and … [Read more…]

Renowned nephrologist and quality of care advocate will lead clinical programs and provider teams in delivering evidence-based, patient-centered care DENVER–(BUSINESS WIRE)–Strive Health, the national leader in value-based kidney care, welcomes Keith Bellovich, D.O., as its Chief Nephrologist. In this role, Dr. Bellovich will partner with the Chief Clinical Officer and other clinical leadership to drive … [Read more…]

Funding supports advancing therapeutic programs toward clinical development, expanding discovery across novel payload classes to accelerate next-generation degrader-antibody conjugate (DAC) programs and broadening Orum’s global capabilities and operations Participation from leading new investors and renewed commitment from long-time supporters signals strong confidence in Orum’s scientific direction, providing a solid foundation for the company’s next stage … [Read more…]

TOKYO–(BUSINESS WIRE)–3D Investment Partners Pte. Ltd. (together with the Fund, “3D” or the “Company”) provides discretionary investment management services to an investment fund which is a shareholder of Toho Holdings Co., Ltd. (TOKYO: 8129, “Toho HD”) (collectively referred to “3D” or “we” together with the investment fund) sent an open letter to the outside directors … [Read more…]